Cara Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cara Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Cara Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $193M, a 19.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $193M +$32M +19.9% Dec 31, 2023 10-K 2024-03-06
Q4 2022 $161M +$17.4M +12.2% Dec 31, 2022 10-K 2024-03-06
Q4 2021 $143M +$22.7M +18.8% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $121M +$6.53M +5.72% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $114M +$24.3M +27.1% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $89.8M +$23.6M +35.7% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $66.2M -$618K -0.93% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $66.8M +$23.8M +55.2% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $43M +$10.3M +31.5% Dec 31, 2015 10-K 2017-03-10
Q4 2014 $32.7M +$7.16M +28% Dec 31, 2014 10-K 2016-03-11
Q4 2013 $25.6M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.